Protalix BioTherapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $15.9M | $81.3M |
| FY2010 | — | $-11.3M | $35.9M |
| FY2011 | $6.6M | $-26.1M | $27.0M |
| FY2012 | $5.4M | $-3.4M | $52.0M |
| FY2013 | $2.4M | $-26.9M | $86.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $15.9M | $81.3M |
| FY2010 | — | $-11.3M | $35.9M |
| FY2011 | $6.6M | $-26.1M | $27.0M |
| FY2012 | $5.4M | $-3.4M | $52.0M |
| FY2013 | $2.4M | $-26.9M | $86.4M |